Here are four trends:
1. The use of surface-modified titanium in cervical spine implants is thought to be the primary driver of the market.
2. Prevalence of cervical herniated disc in geriatric population and use of non-fusion spinal procedures are other drivers of the market.
3. Additionally, the market is expected to see the launch of many novel pipeline products from 2016 to 2020.
4. Currently, there are five cervical artificial discs developed by companies such as Medtronic, LDR and Globus Medical involved in Phase III clinical trials.
More articles on devices:
All MACs to cover Osiris Therapeutics’ Grafix for wound care: 3 points
Bone Therapeutics, Kasios extend collaboration for spinal fusion product: 3 takeaways
Global outsourced orthopedic manufacturing market to reach $2B+ by 2020: 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
